| Universal prescription drug coverage in Canada: Long-promised yet undelivered SG Morgan, K Boothe Healthcare management forum 29 (6), 247-254, 2016 | 78 | 2016 |
| Toward an understanding of high performance pharmaceutical policy systems: a “triple-a” framework and example analysis S Morgan, J Kennedy, K Boothe, M McMahon, D Watson, E Roughead The Open Health Services and Policy Journal 2 (1), 2009 | 35 | 2009 |
| The influence of institutions on issue definition: Children's environmental health policy in the United States and Canada K Boothe, K Harrison Journal of Comparative Policy Analysis 11 (3), 287-307, 2009 | 29 | 2009 |
| “Getting to the table”: Changing ideas about public and patient involvement in Canadian drug assessment K Boothe Journal of health politics, policy and law 44 (4), 631-663, 2019 | 25 | 2019 |
| Ideas and the pace of change: national pharmaceutical insurance in Canada, Australia, and the United Kingdom K Boothe University of Toronto Press, 2015 | 23 | 2015 |
| Ideas and the limits on program expansion: the failure of nationwide pharmacare in Canada since 1944 K Boothe Canadian Journal of Political Science/Revue canadienne de science politique …, 2013 | 21 | 2013 |
| How the pace of change affects the scope of reform: pharmaceutical insurance in Canada, Australia, and the United Kingdom K Boothe Journal of Health Politics, Policy and Law 37 (5), 779-814, 2012 | 21 | 2012 |
| Prescription drug subsidies in Australia and New Zealand S Morgan, K Boothe Australian prescriber 33 (1), 2010 | 21 | 2010 |
| Trends in Public Engagement in Canadian Health Policy from 2000-2021: Results from a Comparative Descriptive Analysis R Dhamanaskar, J Abelson, K Boothe, J Massie, J You, D Just, G Kuang Public Engagement in Health Policy. https://static1. squarespace. com/static …, 2022 | 8 | 2022 |
| Pharmaceutical policy reform in Canada: lessons from history K Boothe Health Economics, Policy and Law 13 (3-4), 299-322, 2018 | 7 | 2018 |
| School closure decisions in Alberta and Ontario during COVID-19: Discourse and data K Boothe, N Fiorillo, D Just, E Alvarez, A Davidson Canadian Journal of Political Science/Revue canadienne de science politique …, 2022 | 6 | 2022 |
| (Re) defining legitimacy in Canadian drug assessment policy? Comparing ideas over time K Boothe Health Economics, Policy and Law 16 (4), 424-439, 2021 | 6 | 2021 |
| Healthcare management forum 29 (6) Los Angeles SG Morgan, K Boothe CA: SAGE, 2016 | 6 | 2016 |
| Trends in Government-Initiated Public Engagement in Canadian Health Policy from 2000 to 2021 R Dhamanaskar, K Boothe, J Massie, J You, D Just, G Kuang, J Abelson Healthcare Policy 20 (SP), 17, 2024 | 5 | 2024 |
| Pharmaceutical programs and social policy development: comparing Canada, Australia and the UK K Boothe University of British Columbia, 2010 | 3 | 2010 |
| Whom Do I Trust to Represent Me? Long-Term Care Resident and Family Perspectives on Legitimate Representation J You, K Boothe, R Ganann, M Wilson, J Abelson Healthcare Policy 20 (SP), 48, 2024 | 2 | 2024 |
| Recruiting for Engagement in Health Policy J Massie, K Boothe Healthcare Policy 20 (SP), 36, 2024 | 2 | 2024 |
| Evaluating the Cost-effectiveness of Pharmaceuticals in Canada K Boothe Health Reform Observer–Observatoire des Réformes de Santé 4 (1), 2016 | 2 | 2016 |
| PHP25 TOWARD HIGH PERFORMANCE ‘PHARMACARE’SYSTEMS: A REVIEW OF EXPERIENCES IN SEVEN COUNTRIES S Morgan, J Kennedy, L Roughead, K Boothe, M McMahon, D Watson Value in Health 3 (11), A36, 2008 | 2 | 2008 |
| Public Engagement in Health Policy‐Making for Older Adults: A Systematic Search and Scoping Review J You, R Ganann, M Wilson, SC Carusone, M MacNeil, C Whitmore, ... Health Expectations 27 (4), e70008, 2024 | 1 | 2024 |
Steve MorganProfessor of health policy, University of British ColumbiaVerified email at ubc.ca
